carbamazepine has been researched along with Kidney Failure, Chronic in 8 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Porphyria cutanea tarda is a disorder of heme biosynthesis resulting from a defect or deficiency in the enzyme uroporphyrinogen decarboxylase." | 1.29 | Porphyria cutanea tarda in a patient on chronic ambulatory peritoneal dialysis. ( Demento, FJ; Fishbane, S; Frei, GL; Maesaka, JK; Ruggian, JC, 1996) |
| " The half-life and apparent clearance were the same for each day, indicating that hemodialysis/hemoperfusion had little effect on the overall removal of carbamazepine from the body." | 1.28 | Carbamazepine clearance in hemodialysis and hemoperfusion. ( Gal, P; Kandrotas, RJ; Love, JM; Oles, KS, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davison, SN | 1 |
| Ruggian, JC | 1 |
| Fishbane, S | 1 |
| Demento, FJ | 1 |
| Maesaka, JK | 1 |
| Frei, GL | 1 |
| Kaspar, U | 1 |
| Poser, W | 1 |
| Poser, S | 1 |
| Ritter, G | 1 |
| Kremer, GJ | 1 |
| Atzpodien, W | 1 |
| Kandrotas, RJ | 1 |
| Oles, KS | 1 |
| Gal, P | 1 |
| Love, JM | 1 |
| Sedman, AJ | 1 |
| Molitoris, BA | 1 |
| Nakata, LM | 1 |
| Gal, J | 1 |
| Radó, JP | 1 |
| Szende, L | 1 |
| Takó, J | 1 |
1 review available for carbamazepine and Kidney Failure, Chronic
| Article | Year |
|---|---|
[Diphenylhydantoin. Metabolism, pharmacokinetics, interactions and side effects].
Topics: Anti-Anxiety Agents; Benzodiazepines; Bone and Bones; Bone Marrow; Carbamazepine; Cerebellar Disease | 1976 |
7 other studies available for carbamazepine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure.
Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Analgesics, Opioid; Carbamazepine; Chronic Pain | 2019 |
Porphyria cutanea tarda in a patient on chronic ambulatory peritoneal dialysis.
Topics: Adult; Anticonvulsants; Carbamazepine; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis, C | 1996 |
[Drug therapy of epilepsy].
Topics: Age Factors; Anticonvulsants; Barbiturates; Benzodiazepines; Bromides; Carbamazepine; Chlormethiazol | 1977 |
[Fabry's diffuse angiokeratoma corporis].
Topics: Age Factors; Carbamazepine; Fabry Disease; Galactosidases; Glycolipids; Heterozygote; Humans; Kidney | 1975 |
Carbamazepine clearance in hemodialysis and hemoperfusion.
Topics: Carbamazepine; Female; Hemoperfusion; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Mid | 1989 |
Therapeutic drug monitoring in patients with chronic renal failure: evaluation of the Abbott TDx drug assay system.
Topics: Carbamazepine; Cross Reactions; Digoxin; Gentamicins; Humans; Immunoassay; Kidney Failure, Chronic; | 1986 |
Drug-induced inhibition of the diuretic response to water loading in partial vasopressin responsive nephrogenic diabetes insipidus.
Topics: Adult; Carbamazepine; Clofibrate; Diabetes Insipidus; Diuresis; Female; Glomerular Filtration Rate; | 1974 |